🇺🇸 FDA
Patent

US 7666989

Recombinant protein having an anti-cancer effect, its encoding gene and uses thereof

granted A61KA61K38/00A61P

Quick answer

US patent 7666989 (Recombinant protein having an anti-cancer effect, its encoding gene and uses thereof) held by Beijing Sunbio Biotech Co. Ltd. expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Beijing Sunbio Biotech Co. Ltd.
Grant date
Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/00, A61P, A61P35/00